Dabur India Limited recalls Med Pride
- Recalling company
- Dabur India Limited
- Product
- Med Pride, Triple Antibiotic Ointment, Bacitracin Zinc (equivalent to 400 units), Neomycin Sulfate 5 mg, Polymixin B 5000 units, 0.9g packets, 144 packets per box, 130g, Manufactured for: Shield Line LLC, 59 Hook Road, Bayonne, NJ 07002 USA, Made in India, UPC 1 03 52410 30253 1.
- Reason
- CGMP Deviations; deficiencies observed during FDA inspection
- Classification
- Class II – may cause temporary or medically reversible health consequences
- Recall date
- Jun 2, 2026
- Reported
- Jun 24, 2026
- Distribution
- US Nationwide.
- Status
- Ongoing
- Quantity
- 3006 tubes
- Lot / codes
- Lot# 011, 014, 015, 016, 017, 018, 019, 020, 021, 022, 026, Within Expiry.
- Company location
- Dadra And Nagar Haveli
- Recall type
- Voluntary: Firm initiated
- Recall number
- D-0641-2026
- Agency
- U.S. Food and Drug Administration (FDA)
View official FDA notice ↗ Search recall number D-0641-2026 in the FDA Enforcement Report. Also see FDA recall press releases.
If you use this product, check the lot, NDC or model number against the official notice and follow its instructions. Do not stop a prescribed medicine or remove a medical device without talking to your doctor or pharmacist. Report problems to FDA MedWatch. FoodRecallNow summarizes public FDA data and is not medical advice.